title: Ochratoxin a and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A.
abstract: The mycotoxin and food contaminant ochratoxin A (OTA) is a potent renal carcinogen in rodents, but its mode of action (MoA) is still poorly defined. In 2006, the European Food Safety Authority concluded that there is a "lack of evidence for the existence of OTA-DNA adducts" and thus insufficient evidence to establish DNA reactivity as a MoA for tumor formation by OTA. In reviewing the available database on OTA toxicity, a MoA for renal carcinogenicity of OTA is developed that involves a combination of genetic instability and increased proliferative drive as consequences of OTA-mediated disruption of mitosis, whereby the organ- and site-specificity of tumor formation by OTA is determined by selective renal uptake of OTA into the proximal tubule epithelium. The proposed MoA is critically assessed with respect to concordance of dose-response of the suggested key events and tumor formation, their temporal association, consistency, and biological plausibility. Uncertainties, data gaps and needs for further research are highlighted.
authors.affiliation: Department of Toxicology, University of Würzburg, 97078 Würzburg, Germany. mally@toxi.uni-wuerzburg.de
authors.forename: Angela
authors.initials: A
authors.lastname: Mally
mesh_terms: D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced* / Q000235:genetics / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D005506:Food Contamination; D042822:Genomic Instability; D006801:Humans; D007680:Kidney Neoplasms / Q000139:chemically induced* / Q000235:genetics / Q000473:pathology; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008938:Mitosis / Q000187:drug effects*; D009793:Ochratoxins / Q000009:adverse effects* / Q000378:metabolism; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors
chemical_list: D009793:Ochratoxins; C025589:ochratoxin A